Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset حسب P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg

احصل على النص الكامل

Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer حسب P.E. Lonergan, S.L. Washington, S. Zhao, J.E. Cowan, H.G. Nguyen, K. Shinohara, M.R. Cooperberg, P.R. Carroll

احصل على النص الكامل

Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer حسب V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen

احصل على النص الكامل